
Dan Frendl
31 posts

Dan Frendl
@dfrendl
Urologist @MayoUrology in AZ 🌵 🇺🇸 | All opinions are my own and not endorsed by @MayoClinic









Jacob Thatcher, DO has been named the 2024-2025 Holtgrewe Fellow! 🎉 Dr. Thatcher will complete a 6-week fellowship with a legislative office in Washington, DC, and participate in major #AUAAdvocacy initiatives. Congratulations Dr. Thatcher 🎉 ➡️ bit.ly/456dhND



Somehow despite largely single arm small trials and lots of retrospective data that is enough to have an entire meeting to spread training on focal. Let’s be honest. -It is to gain competitive advantage to do something different, not necessarily better - gain quick cash at higher amount than RP that patients easy to agree to given misleading info - as RT has become shorter, less toxic and more effective, need to do something for those not wanting RP to keep your job - you are frankly not good at surgery and have poor functional outcomes but need to justify your job somehow If you truly are doing this for patients then you would do this on an RCT to prove it is superior than AS or SBRT and help millions of men. If truly for patients you would not risk harming patients off trial which is happening unquestionable. I have patients catheter dependent after nanoknife that was done in Europe…guess where. Out lots of money and now has M1 dz with a catheter.


























